What's in OPKO Health, Inc.'s pipeline?

OPKO Health, Inc. has 15 drugs in our index: 3 marketed, 0 filed, 1 in Phase 3, 6 in Phase 2, 5 in Phase 1.

Which companies overlap with OPKO Health, Inc.'s portfolio?

Top competitors by shared drug class: LEO Pharma, Balmoral Medical company, Edesa Biotech Inc., Cerium Pharmaceuticals, Inc., Department of Medical Services Ministry of Public Health of Thailand.

How do I subscribe to ongoing alerts?

Subscribe to /feed/company/opko-health-inc.xml in any RSS reader. Every regulatory action and pipeline update lands in your feed.

Last reviewed 2026-05-18 · How we verify

OPKO Health, Inc. — Portfolio Competitive Intelligence Brief

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OPKO Health, Inc. pipeline: 3 marketed, 0 filed, 1 Phase 3, 6 Phase 2. Recent regulatory actions, upcoming PDUFA, patent timeline, top competitor overlap.

3 marketed 0 filed 1 Phase 3 6 Phase 2 5 Phase 1 Live · 30-min refresh

Portfolio leaders (marketed + Phase 3 / filed)

Drug	Generic	Phase	Class	Target	Area
Rayaldee	Rayaldee	marketed			Other
Calcifediol Oral Capsule	Calcifediol Oral Capsule	marketed
Calcifediol Oral Product	Calcifediol Oral Product	marketed	Vitamin D analog	Vitamin D receptor (VDR)	Endocrinology / Nephrology
CTAP101 Capsules	CTAP101 Capsules	phase 3	Vitamin D analog	Vitamin D receptor (VDR)	Nephrology / Endocrinology

Therapeutic area mix

Bone disorders · 1
Dermatology · 1
Endocrinology / Nephrology · 1
Nephrology / Endocrinology · 1
Osteoporosis · 1
Other · 1

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this portfolio.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this portfolio.

Patent timeline (forward window)

No upcoming patent expiries for this portfolio.

Competitive overlap (companies sharing drug classes)

LEO Pharma · 2 shared drug classes
Balmoral Medical company · 1 shared drug class
Edesa Biotech Inc. · 1 shared drug class
Cerium Pharmaceuticals, Inc. · 1 shared drug class
Department of Medical Services Ministry of Public Health of Thailand · 1 shared drug class
Dr. Reddys Laboratories, SA · 1 shared drug class
Bausch & Lomb Incorporated · 1 shared drug class
American Regent, Inc. · 1 shared drug class

Subscribe to ongoing alerts

Every new pipeline event for OPKO Health, Inc.:

Cite this brief

Drug Landscape (2026). OPKO Health, Inc. — Portfolio Competitive Intelligence Brief. https://druglandscape.com/ci/company/opko-health-inc. Accessed 2026-05-18.